{
  "resultsSection": {
    "outcomeMeasuresModule": {
      "outcomeMeasures": [
        {
          "analyses": [
            {
              "groupIds": [
                "OG000",
                "OG001"
              ],
              "groupDescription": "Odds ratio: CZP/Placebo and p-value were calculated using logistic regression with factors for treatment, region and Magnetic Resonance Imaging/C- Reactive Protein (MRI/CRP) classification.",
              "nonInferiorityType": "OTHER",
              "nonInferiorityComment": "Weeks 8 and 24",
              "pValue": "<0.001",
              "pValueComment": "with significance level of 0.025",
              "statisticalMethod": "Regression, Logistic",
              "statisticalComment": "Treatment and baseline pain categorical score were factors.",
              "paramType": "Odds Ratio (OR)",
              "paramValue": "15.231",
              "ciPctValue": "95",
              "ciNumSides": "TWO_SIDED",
              "ciLowerLimit": "7.336",
              "ciUpperLimit": "31.623"
            }
          ]  
        },
        {
          "analyses": [
            {
              "groupIds": [
                "OG000",
                "OG001"
              ],
              "groupDescription": "Odds ratio: CZP/Placebo and p-value were calculated using logistic regression with factors for treatment, region and MRI/CRP classification.",
              "nonInferiorityType": "OTHER",
              "nonInferiorityComment": "4 letter margin (1-sided)",
              "pValue": "<0.001",
              "statisticalMethod": "Regression, Logistic",
              "paramType": "Odds Ratio (OR)",
              "paramValue": "7.436",
              "ciPctValue": "95",
              "ciNumSides": "TWO_SIDED",
              "ciLowerLimit": "4.127",
              "ciUpperLimit": "13.401",
              "ciUpperLimitComment": "Due to smaller number of participants with an event, upper limit of 95% CI could not be calculated.",
              "estimateComment": "Hazard ratio and its CIs were estimated from Cox Proportional hazards model stratified by FLIPI2 risk categorization.",
              "otherAnalysisDescription": "The mean difference is actually adjusted mean of difference and the dispersion value is standard error of differences.",
              "dispersionType": "STANDARD_ERROR_OF_MEAN",
              "dispersionValue": "0.73"     
            }
          ]
        },
        {
          "analyses": [
            {
              "groupIds": [
                "OG000",
                "OG001"
              ],
              "groupDescription": "Odds ratio: CZP/Placebo and p-value were calculated using logistic regression with factors for treatment, region MRI/CRP classification.",
              "nonInferiorityType": "OTHER",
              "pValue": "<0.001",
              "pValueComment": "p-value for treatment difference",
              "statisticalMethod": "Regression, Logistic",
              "statisticalComment": "A log-rank test stratified by FLIPI2 risk was used to compare the treatment groups with respect to PFS at a 2-sided alpha level of 0.05.",
              "paramType": "Odds Ratio (OR)",
              "paramValue": "7.359",
              "ciPctValue": "95",
              "ciNumSides": "TWO_SIDED",
              "ciLowerLimit": "4.286",
              "ciUpperLimit": "12.636"
            },
            {
              "groupIds": [
                "OG000",
                "OG001"
              ],
              "nonInferiorityType": "SUPERIORITY",
              "nonInferiorityComment": "Week 64",
              "pValue": "0.331",
              "statisticalMethod": "ANCOVA",
              "paramType": "LS Mean Difference",
              "paramValue": "-1.1",
              "ciPctValue": "95",
              "ciNumSides": "TWO_SIDED",
              "ciLowerLimit": "-3.4",
              "ciUpperLimit": "1.2"
            }
          ]
        },
        {
          "analyses": [
            {
              "groupIds": [
                "OG000",
                "OG001"
              ],
              "groupDescription": "From an ANCOVA model including scores at Baseline, treatment group, region and MRI/CRP classification.",
              "nonInferiorityType": "OTHER",
              "nonInferiorityComment": "Week 18",
              "pValue": "<0.001",
              "statisticalMethod": "ANCOVA",
              "statisticalComment": "Treatment and baseline pain categorical score were factors.",
              "paramType": "Difference",
              "paramValue": "-1.696",
              "ciPctValue": "95",
              "ciNumSides": "TWO_SIDED",
              "ciLowerLimit": "-2.110",
              "ciUpperLimit": "-1.282",
              "ciUpperLimitComment": "Upper limit of the confidence interval is not reached due to censoring rate.",
              "estimateComment": "The Kaplan Meier method was used to estimate median OS(in months). The Greenwood method was used to estimate confidence limits of median overall survival.",
              "otherAnalysisDescription": "Hazard Ratio (HR) (Dex/PBO)"
            }
          ]
        },
        {
          "analyses": [
            {
              "groupIds": [
                "OG000",
                "OG001"
              ],
              "groupDescription": "From an ANCOVA model including scores at Baseline, treatment group, region and MRI/CRP classification.",
              "nonInferiorityType": "OTHER",
              "nonInferiorityComment": "Week 13",
              "pValue": "<0.0001",
              "statisticalMethod": "ANCOVA",
              "paramType": "Difference",
              "paramValue": "-1.585",
              "ciPctValue": "95",
              "ciNumSides": "TWO_SIDED",
              "ciLowerLimit": "-2.132",
              "ciUpperLimit": "-1.038",
              "dispersionType": "STANDARD_ERROR_OF_MEAN",
              "dispersionValue": "9.87"
            },
            {
              "groupIds": [
                "OG000",
                "OG001"
              ],
              "nonInferiorityType": "SUPERIORITY",
              "nonInferiorityComment": "Week 16",
              "pValue": "<0.0001",
              "statisticalMethod": "likelihood ratio test",
              "statisticalComment": "Assessed at one-sided 0.025 significance level",
              "paramType": "Odds Ratio (OR)",
              "paramValue": "2.6",
              "ciPctValue": "95",
              "ciNumSides": "TWO_SIDED",
              "ciLowerLimit": "1.7",
              "ciUpperLimit": "3.9",
              "dispersionType": "STANDARD_ERROR_OF_MEAN",
              "dispersionValue": "11.26"
            }
          ]
        }
      ]  
    }
  }
}